Hunterian Medicine is a gene editing company based in Cambridge, Massachusetts. Their mission is to cure genetic diseases by utilizing their innovative CRISPR delivery technology. Currently, there are approximately 6,000-7,000 known genetic disorders, such as ALS, cystic fibrosis, muscular dystrophy, and Fuchs' dystrophy, affecting millions of people worldwide.

Unfortunately, over 95% of these diseases lack any FDA-approved treatments or cures. However, CRISPR, a groundbreaking gene-editing tool, has the potential to correct disease-causing mutations within the human genome. Unlike traditional medical research that focuses on managing symptoms, Hunterian's approach aims to permanently cure genetic disorders by directly correcting DNA mutations.

To facilitate this, they have developed a unique genetic element that enables safe and effective delivery of the genome-editing technology into human cells (in vivo) using a single adeno-associated virus (AAV). By harnessing CRISPR's potential, Hunterian Medicine is poised to revolutionize the treatment of genetic diseases and deliver the cures that millions of people desperately need